- Animal & Veterinary
Recipient NameMark C. Haverkamp
- Valley View Milling LLC
2875 State Highway 63
Seneca, KS 66538-2145
- Issuing Office:
- Office of Human and Animal Food- West Division II
Dear Mr. Haverkamp,
The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter CMS 626198 dated May 17, 2022. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
LaTonya M. Mitchell, Ph.D.
Program Division Director
Office of Human and Animal Foods, Division West II